<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>4792</number>
    <updateDate>2023-01-13T04:49:09Z</updateDate>
    <updateDateIncludingText>2023-01-13T04:49:09Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2006-02-16</introducedDate>
    <congress>109</congress>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2006-02-17T16:01:49Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2006-02-16T15:02:50Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2006-02-16T15:03:05Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hswm00</systemCode>
        <name>Ways and Means Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2006-02-16T15:03:00Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Pharmaceutical Market Access Act of 2005</title>
        <congress>109</congress>
        <number>328</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2005-06-21</actionDate>
          <text>Sponsor introductory remarks on measure. (CR H4861)</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Suspension of Medicare Prescription Drug Late Enrollment Penalty Act of 2006</title>
        <congress>109</congress>
        <number>5173</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2006-04-25</actionDate>
          <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Improving Access to Medicare Part D Act of 2006</title>
        <congress>109</congress>
        <number>5297</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2006-05-15</actionDate>
          <text>Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman .</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2006-02-17</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2006-02-16</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2006-02-16</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2006-02-16</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100-A</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-02-16</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2006-02-16</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-02-16</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>L000560</bioguideId>
        <fullName>Rep. Larsen, Rick [D-WA-2]</fullName>
        <firstName>RICK</firstName>
        <lastName>LARSEN</lastName>
        <party>D</party>
        <state>WA</state>
        <district>2</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>M000404</bioguideId>
        <fullName>Rep. McDermott, Jim [D-WA-7]</fullName>
        <firstName>JIM</firstName>
        <lastName>MCDERMOTT</lastName>
        <party>D</party>
        <state>WA</state>
        <district>7</district>
        <sponsorshipDate>2006-02-16</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000327</bioguideId>
        <fullName>Rep. Dicks, Norman D. [D-WA-6]</fullName>
        <firstName>NORMAN</firstName>
        <lastName>DICKS</lastName>
        <party>D</party>
        <state>WA</state>
        <district>6</district>
        <sponsorshipDate>2006-03-02</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative fees</name>
        </item>
        <item>
          <name>Administrative procedure</name>
        </item>
        <item>
          <name>Business records</name>
        </item>
        <item>
          <name>Civil actions and liability</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Congress</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Consumer education</name>
        </item>
        <item>
          <name>Consumer protection</name>
        </item>
        <item>
          <name>Cost control</name>
        </item>
        <item>
          <name>Damages</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Directories</name>
        </item>
        <item>
          <name>Drug approvals</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Drugs</name>
        </item>
        <item>
          <name>Electronic commerce</name>
        </item>
        <item>
          <name>Evidence (Law)</name>
        </item>
        <item>
          <name>Finance and Financial Sector</name>
        </item>
        <item>
          <name>Foreign Trade and International Finance</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Government and business</name>
        </item>
        <item>
          <name>Government paperwork</name>
        </item>
        <item>
          <name>Government publicity</name>
        </item>
        <item>
          <name>Governmental investigations</name>
        </item>
        <item>
          <name>Health insurance</name>
        </item>
        <item>
          <name>Health maintenance organizations</name>
        </item>
        <item>
          <name>Identification devices</name>
        </item>
        <item>
          <name>Import restrictions</name>
        </item>
        <item>
          <name>Imports</name>
        </item>
        <item>
          <name>Injunctions</name>
        </item>
        <item>
          <name>Insurance premiums</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Internet</name>
        </item>
        <item>
          <name>Labeling</name>
        </item>
        <item>
          <name>Law</name>
        </item>
        <item>
          <name>Licenses</name>
        </item>
        <item>
          <name>Managed care</name>
        </item>
        <item>
          <name>Medical economics</name>
        </item>
        <item>
          <name>Medicare</name>
        </item>
        <item>
          <name>Packaging</name>
        </item>
        <item>
          <name>Parties to actions</name>
        </item>
        <item>
          <name>Patent infringement</name>
        </item>
        <item>
          <name>Patents</name>
        </item>
        <item>
          <name>Pharmacies</name>
        </item>
        <item>
          <name>Pharmacists</name>
        </item>
        <item>
          <name>Prescription pricing</name>
        </item>
        <item>
          <name>Price discrimination</name>
        </item>
        <item>
          <name>Product counterfeiting</name>
        </item>
        <item>
          <name>Punitive damages</name>
        </item>
        <item>
          <name>Quality of care</name>
        </item>
        <item>
          <name>Restrictive trade practices</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Social Welfare</name>
        </item>
        <item>
          <name>Standards</name>
        </item>
        <item>
          <name>Wholesale trade</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2006-02-16</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2006-04-20T14:13:50Z</updateDate>
        <text><![CDATA[ <p>Fix Medicare Part D Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to repeal provisions prohibiting the Secretary of Health and Human Services from interfering with negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors. Requires the Secretary to negotiate contracts with manufacturers of covered part D drugs to purchase prescription drugs in order to ensure that beneficiaries under Medicare prescription drug plans pay the lowest possible price.</p> <p>Pharmaceutical Market Access Act of 2006 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to promulgate regulations permitting pharmacists, pharmacies, wholesalers, and individuals to import qualifying drugs from certain countries into the United States.</p> <p>Deems a prescription drug to be misbranded unless the packaging of such drug complies with the requirements for counterfeit-resistant technologies.</p> <p>Prohibits: (1) failing to register in accordance with this Act; and (2) importing or offering to import a prescription drug in violation of a suspension order.</p> <p>Declares that selling or importing a patented drug in the United States that was first sold abroad by or under authority of the owner or licensee of the patent is not patent infringement.</p> <p>Prohibits drug manufacturers from discriminating against a person that engages in the importation of a prescription drug, including by charging higher prices or denying supplies of the drug.</p> <p>Extends the 2006 annual coordinated election period for enrollment in a Medicare prescription drug plan until November 14, 2006. Suspends until after December 2006 any penalties for late enrollment in such a plan.</p>]]></text>
      </summary>
    </summaries>
    <title>Fix Medicare Part D Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Fix Medicare Part D Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To fix the Medicare Part D prescription drug program by requiring the Secretary of Health and Human Services to negotiate fair prices for prescription drugs on behalf of Medicare beneficiaries, to further reduce drug costs to consumers by allowing the importation of prescription drugs under the Federal Food, Drug, and Cosmetic Act, to provide seniors with adequate time to consider their options under Medicare part D by extending the 2006 Medicare prescription drug enrollment period through December 31, 2006, without penalty, and for other purposes.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Fix Medicare Part D Act</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced for portions of this bill</titleType>
        <title>Pharmaceutical Market Access Act of 2006</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2006-02-16T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-109hr4792ih/xml/BILLS-109hr4792ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2006-02-17</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
